Table 7.

Exercise prescription.

		Total cohort	Test completed						Contraindicated	Deferred
			At pace		Slower self-paced		Shorter self-paced	Flat self-paced
Cancer survivors (total n per group)		169	88		24		21	9	20	7
		Number provided exercise prescription number (%)
Exercise prescription intensitya,b Number (% column total)		154 (91)	84 (95)		21 (88)		19 (90)	9 (100)	15 (75)	6 (86)
Sedentary		3	0		0		0	0	3c	0
Light		96	41		19		15	9	12	0
Moderate		41	33		2		4	0	0	2
Vigorous		14	10		0		0	0	0	4
		Number not provided exercise prescription number (%)
No exercise prescription Number (% column total)		15 (9)	4 (5)		3 (12)		2 (10)	0 (0)	5 (25)	1 (14)
Consultation required before exercise Rxd		12	4		3		2	0	3	0
Healing required before exercise Rxe		2	0		0		0	0	2	0
Declined exercise Rxf		1	0		0		0	0	0	1

SEM: standard error of the mean.

^aExercise Rx: at pace vs. slower self-paced p = 0.0023, at pace vs. shorter self-paced p = 0.0483, at pace vs. flat self-paced p = 0.0190, at pace vs. contraindicated p = 0.0000, At pace vs. deferred p = 0.0012, Fisher's exact, two-tailed.

^bCurrent exercise Hx (Table 2) vs. exercise Rx: total cohort p = 0.0000, at pace p = 0.0000, chi square, two-tailed. slower self-paced p = 0.0001, shorter self-paced p = 0.0002, contraindicated p = 0.0003, Fisher's exact, two-tailed.

^cN = 1 balance exercises. N = 1 range of motion exercises. N = 1 activities of daily living only.

^dN = 8 cardiac stress test, N = 1 each: exercise-induced cardiac arrythmia, MRI shoulder, Baker's cyst, left upper quadrant pain.

^eN = 1 each: onycholysis, surgical incision.

^fN = 1 came to clinic for tamoxifen consultation.